Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.33 |
| ▸ | PRKCG | P05129 | 1/20 | 0.33 |
| ▸ | PRKCB | P05771 | 1/20 | 0.33 |
| ▸ | PRKCA | P17252 | 1/20 | 0.33 |
| ▸ | PRKCH | P24723 | 1/20 | 0.33 |
| ▸ | PRKCI | P41743 | 1/20 | 0.33 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.33 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.33 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.33 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.33 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7738197 | 0.96 | ACE2 (0.46) | ACE2MAPTLMNAPRKD3PRKCG | |
| SCHEMBL7744131 | 0.94 | ACE2 (0.44) | ACE2MAPTLMNAPRKD3PRKCG | |
| SCHEMBL23924161 | 0.94 | ACE2 (0.44) | ACE2MAPTLMNAPRKD3PRKCG | |
| SCHEMBL31521582 | 0.94 | ACE2 (0.42) | ACE2MAPTLMNAPRKD3PRKCG | |
| SCHEMBL31521496 | 0.94 | MAPT (0.39) | ACE2MAPTLMNAPRKD3PRKCG | |
| SCHEMBL23923682 | 0.92 | ACE2 (0.50) | ACE2LMNAPRKD3PRKCGPRKCB | |
| SCHEMBL31521579 | 0.89 | MAPT (0.39) | ACE2MAPTLMNAPRKD3PRKCG | |
| SCHEMBL7744113 | 0.89 | ACE2 (0.42) | ACE2MAPTLMNAPRKD3PRKCG | |
| SCHEMBL7744198 | 0.88 | ACE2 (0.46) | ACE2LMNAPRKD3PRKCGPRKCB | |
| SCHEMBL31521581 | 0.88 | ACE2 (0.41) | ACE2MAPTLMNAPRKD3PRKCG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025264609-A1 | C20 TRISUBSTITUTED OLEFINS PRODUCED BY ACIDIC CATALYZED REACTION OF C20 2-SUBSTITUTED ALPHA OLEFINS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-12-26 | — | — | WO | claimed |
| US-20250382242-A1 | C20 TRISUBSTITUTED OLEFINS PRODUCED BY ACIDIC CATALYZED REACTION OF C20 2-SUBSTITUTED ALPHA OLEFINS | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2025-12-18 | — | — | US | claimed |
| US-20250075015-A1 | POLYALPHAOLEFINS MADE FROM DIMER OLEFINS OBTAINED FROM BRANCHED C10 MONOOLEFINS USING ALKYL ALUMINUM CATALYST | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2025-03-06 | — | — | US | claimed |
| WO-2025049097-A1 | POLYALPHAOLEFINS MADE FROM DIMER OLEFINS OBTAINED FROM BRANCHED C10 MONOOLEFINS USING ALKYL ALUMINUM CATALYST | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-03-06 | — | — | WO | claimed |
| US-11174205-B2 | C20 2-substituted alpha olefins produced by dimerization of branched C10 olefins | CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) | 2021-11-16 | — | — | US | claimed |
| US-20210323892-A1 | C20 2-Substituted Alpha Olefins Produced By Dimerization Of Branched C10 Olefins | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2021-10-21 | — | — | US | claimed |
| WO-2025264609-A1 | C20 TRISUBSTITUTED OLEFINS PRODUCED BY ACIDIC CATALYZED REACTION OF C20 2-SUBSTITUTED ALPHA OLEFINS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-12-26 | — | — | WO | disclosed |
| US-20250382242-A1 | C20 TRISUBSTITUTED OLEFINS PRODUCED BY ACIDIC CATALYZED REACTION OF C20 2-SUBSTITUTED ALPHA OLEFINS | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2025-12-18 | — | — | US | disclosed |
| US-20250075015-A1 | POLYALPHAOLEFINS MADE FROM DIMER OLEFINS OBTAINED FROM BRANCHED C10 MONOOLEFINS USING ALKYL ALUMINUM CATALYST | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2025-03-06 | — | — | US | disclosed |
| WO-2025049097-A1 | POLYALPHAOLEFINS MADE FROM DIMER OLEFINS OBTAINED FROM BRANCHED C10 MONOOLEFINS USING ALKYL ALUMINUM CATALYST | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-03-06 | — | — | WO | disclosed |
| US-11174205-B2 | C20 2-substituted alpha olefins produced by dimerization of branched C10 olefins | CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) | 2021-11-16 | — | — | US | disclosed |
| US-20210323892-A1 | C20 2-Substituted Alpha Olefins Produced By Dimerization Of Branched C10 Olefins | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2021-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250382242-A1 | C20 TRISUBSTITUTED OLEFINS PRODUCED BY ACIDIC CATALYZED REACTION OF C20 2-SUBSTITUTED ALPHA OLEFINS | COASY, MOGAT2, HSD17B12 | ACE2 2252/4885MAPT 4118/4885LMNA 4311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.